Perirectal seeds as a risk factor for prostate brachytherapy-related rectal bleeding

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 4, 2004, Pages 1047-1052

  Mueller, Amy ^a   Wallner, Kent ^a,b,c   Merrick, Gregory ^d   Ford, Eric ^a,b   Sutlief, Steven ^a,b   Cavanagh, William ^a   Butler, Wayne ^d  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d WHEELING HOSPITAL   (United States)

Author keywords

Brachytherapy; Morbidity; Prostatic carcinoma; Rectum

Indexed keywords

DOSIMETERS; PATIENT TREATMENT; RADIOTHERAPY; REGRESSION ANALYSIS; RISKS;

PROSTATE; RECTAL WALL;

ONCOLOGY;

IODINE 125; PALLADIUM 103;

BRACHYTHERAPY; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DOSIMETRY; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSTATE; RADIATION DOSE; RECTUM; RECTUM HEMORRHAGE; REVIEW; RISK FACTOR; STATISTICAL SIGNIFICANCE; TELEPHONE;

EID: 3042658247     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.12.016     Document Type: Article

References (17)

1. Snyder K.M., Stock R.G., Hong S.M., et al. Defining the risk of developing grade 2 proctitis following 125-I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 50:2001;335-341
2. Gelblum D.Y., Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 48:2000;119-124
3. Waterman F.M., Dicker A.P. Probability of late rectal morbidity in I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 55:2003;342-353
4. Merrick G.S., Butler W.M., Dorsey A.T., et al. Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 43:1999;1021-1027
5. Hu K., Wallner K. Clinical course of rectal complications following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 41:1998;263-265
6. Smith S., Wallner K., Han B., et al. Argon plasma coagulation for rectal bleeding following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 51:2001;636-642
7. Howard A., Wallner K., Han B., et al. Clinical course and dosimetry of rectal fistulas after prostate brachytherapy. J Brachyther Int. 17:2001;37-42
8. Theodorescu D., Gillenwater J.Y., Koutrouvelis P.G. Prostatourethral- rectal fistula after prostate brachytherapy Incidence and risk factors. Cancer. 89:2000;2085-2091
9. Wallner K., Blasko J., Dattoli M. Morbidity. Dattoli M. Prostate brachytherapy made complicated. 2nd ed:2001;15.1-15.21 SmartMedicine Press, Seattle
10. Han B., Wallner K. Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications. Int J Cancer. 96:2002;372-378
11. Wallner K., Merrick G., True L., et al. I-125 versus Pd-103 for low risk prostate cancer Morbidity outcomes from a prospective randomized multicenter trial. Ca J Sci American. 8:2002;67-73
12. Mueller A., Wallner K., Corriveau J., et al. A reappraisal of local anesthesia for prostate brachytherapy. Radiother Oncol. 67:2003;309-312
13. Merrick G.S., Butler W.M. Modified uniform seed loading for prostate brachytherapy Rationale, design, and evaluation. Techniques Urol. 6:2000;78-84
14. Han B., Wallner K., Aggarwal S., et al. Treatment margins for prostate brachytherapy. Semin Urol Oncol. 18:2000;137-141
15. Badiozamani K.R., Wallner K.E., Cavanagh W., et al. Comparability of CT-based and TRUS-based prostate volumes. Int J Radiat Oncol Biol Phys. 43:1999;375-378
16. Hilts M., Spandinger I., Keyes M. Comparison of methods for calculating rectal dose after 125-I prostate brachytherapy implants. Int J Radiat Oncol Biol Phys. 53:2002;775-785
17. Waterman F.M., Dicker A.P. Effect of post-implant edema on the rectal dose in prostate brachytherapy. Int J Radiat Oncol Biol Phys. 45:1999;571-576